Portfolio company
Auristone
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops epigenomic profiling tools and bioinformatics services for clinicians and researchers to support precision medicine and cancer drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Epigenica
This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
Xeomics
This company develops bioinformatics software and precision medicine platforms for doctors, pharmaceutical researchers, and national healthcare systems.
OncoPrecision
The company develops patient-derived micro-avatar models and therapeutic antibodies to provide oncology drug discovery and precision medicine services for pharmaceutical partners and clinicians.
Auransa
This biotechnology company develops precision medicines for cancer and other diseases using an artificial intelligence platform to identify novel therapies and patient subgroups.
Precede Biosciences
The company develops an epigenomic liquid biopsy platform for biopharmaceutical companies and researchers to profile gene expression and disease biology from blood samples.
Acrivon Therapeutics
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
